a public good project by the
Synthesis
Company
of California

© 2026

Min Zi | doi.page

0 works0 citations0 h-index

Min Zi

Manchester Academic Health Science Centre(GB)University of Manchester(GB)

Publications by Year

Research Areas

Cardiac Fibrosis and Remodeling, Cardiac electrophysiology and arrhythmias, Signaling Pathways in Disease, Cardiovascular Function and Risk Factors, Hippo pathway signaling and YAP/TAZ

Most-Cited Works

→ A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains(2013)522 cited
→ Pak1 as a Novel Therapeutic Target for Antihypertrophic Treatment in the Heart(2011)132 cited
→ Neuronal Nitric Oxide Synthase Signaling in the Heart Is Regulated by the Sarcolemmal Calcium Pump 4b(2007)105 cited
→ Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU‐MP‐1, protects the heart against adverse effects during pressure overload(2019)93 cited
→ Metabolic stress-induced cardiomyopathy is caused by mitochondrial dysfunction due to attenuated Erk5 signaling(2017)86 cited
→ Targeted Deletion of the Extracellular Signal-Regulated Protein Kinase 5 Attenuates Hypertrophic Response and Promotes Pressure Overload–Induced Apoptosis in the Heart(2010)81 cited

→ Plasma Membrane Calcium Pump (PMCA4)-Neuronal Nitric-oxide Synthase Complex Regulates Cardiac Contractility through Modulation of a Compartmentalized Cyclic Nucleotide Microdomain(2011)

79 cited

→ The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy(2016)71 cited

→ Cardiac-Specific Deletion of Mkk4 Reveals Its Role in Pathological Hypertrophic Remodeling but Not in Physiological Cardiac Growth(2009)69 cited

→ A Novel Immunomodulator, FTY-720 Reverses Existing Cardiac Hypertrophy and Fibrosis From Pressure Overload by Targeting NFAT (Nuclear Factor of Activated T-cells) Signaling and Periostin(2013)64 cited